| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Mar 2023 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.24B | 947.70M | 693.72M | 735.64M | 811.39M |
| Gross Profit | 510.62M | 342.43M | 185.50M | 208.00M | 299.80M |
| EBITDA | 601.29M | 359.10M | 117.38M | 177.74M | 296.02M |
| Net Income | 206.14M | 97.00M | -55.01M | 2.96M | 76.93M |
Balance Sheet | |||||
| Total Assets | 2.16B | 1.65B | 1.42B | 1.42B | 1.45B |
| Cash, Cash Equivalents and Short-Term Investments | 320.02M | 100.78M | 89.13M | 143.84M | 386.79M |
| Total Debt | 344.11M | 319.31M | 351.16M | 321.87M | 304.91M |
| Total Liabilities | 1.28B | 964.15M | 747.23M | 694.57M | 695.27M |
| Stockholders Equity | 721.85M | 610.87M | 608.46M | 657.24M | 695.55M |
Cash Flow | |||||
| Free Cash Flow | 219.23M | 32.57M | -83.62M | -230.79M | 132.34M |
| Operating Cash Flow | 432.81M | 321.25M | 178.76M | 102.92M | 284.70M |
| Investing Cash Flow | -236.08M | -277.00M | -245.51M | -337.58M | -183.43M |
| Financing Cash Flow | 28.20M | -34.82M | 22.77M | -6.59M | 57.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £336.20M | 2.17 | 40.73% | ― | 61.98% | 164.33% | |
76 Outperform | £3.00B | 5.55 | 39.66% | 1.35% | 40.46% | 66.57% | |
73 Outperform | £225.69M | 4.30 | 34.96% | ― | 44.89% | 120.82% | |
71 Outperform | £3.17B | 17.24 | 29.48% | 0.31% | 35.83% | 397.32% | |
66 Neutral | £25.19M | 1.09 | 4.67% | 2.48% | -22.04% | -75.70% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
47 Neutral | £257.27M | 13.71 | -12.56% | ― | 129.53% | 70.68% |